Population pharmacokinetic analysis of meropenem in Japanese adult patients.

Meropenem is frequently employed as an empirical treatment for serious infections, but there has been no report on its population pharmacokinetic parameters for Japanese patients. Our aim is to undertake a population pharmacokinetic analysis of meropenem using non-linear mixed effects model (NONMEM)...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacy & Therapeutics Vol. 36; no. 2; pp. 230 - 237
Autores principales: Muro, T., Sasaki, T., Hosaka, N., Umeda, Y., Takemoto, S., Yamamoto, H., Kamimura, H., Higuchi, S., Karube, Y.
Formato: equations & formulas research tables/charts Journal Article
Publicado: Wiley-Blackwell Apr2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104827396&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104827396
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02694727
        EV4
      jtl: Journal of Clinical Pharmacy & Therapeutics
      issn: 02694727
      maglogo: Y
    pubinfo:
      dt: Apr2011
      vid: 36
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        104827396
        58757522
        10.1111/j.1365-2710.2010.01171.x
        NLM21366653
        104827396
      ppf: 230
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Population pharmacokinetic analysis of meropenem in Japanese adult patients.
      aug:
        au:
          Muro, T.
          Sasaki, T.
          Hosaka, N.
          Umeda, Y.
          Takemoto, S.
          Yamamoto, H.
          Kamimura, H.
          Higuchi, S.
          Karube, Y.
        affil: Department of Pharmacy, Iizuka Hospital
      sug:
        subj:
          Antibiotics Administration and Dosage
          Antibiotics Pharmacokinetics
          Creatinine Blood
          Infection Drug Therapy
          Meropenem
          Human
          Asians
          Japan
          Adult
          Male
          Female
          Goodness of Fit Chi Square Test
          Dose-Response Relationship, Drug
          Time Factors
          Chromatography, Liquid
          Descriptive Statistics
          Causal Modeling
          Middle Age
          Aged
          Mann-Whitney U Test
          Chi Square Test
          Post Hoc Analysis
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Meropenem is frequently employed as an empirical treatment for serious infections, but there has been no report on its population pharmacokinetic parameters for Japanese patients. Our aim is to undertake a population pharmacokinetic analysis of meropenem using non-linear mixed effects model (NONMEM). Data from 68 patients were analysed via NONMEM with the first-order method. The participants' covariates, including gender, age, actual body weight, serum creatinine, serum albumin, serum total protein and creatinine clearance, were analyzed by the forward inclusion and backward elimination method to identify their potential influence on meropenem pharmacokinetics. The adequacy of the constructed model was assessed by goodness-of-fit plots and the precision of the parameter estimated at each step of the model development. To assess the robustness of the estimated parameter, bootstrap analysis was performed. The data were best described by a one-compartment model. The serum creatinine values modified by the below normal limit in our hospital (mSCR) were an influential covariate for clearance (CL): CL (L/h) = 11·1 × (mSCR/0·7). The volume of distribution was estimated as 33·6 L. The coefficient of variation of the inter-individual variability of CL and the residual variability were 52·1% and 0·827% μg/mL, respectively. A comparison of the population pharmacokinetic parameters of meropenem in the final model estimated in NONMEM with original data, and 1000 bootstrap samples shows that both sets of estimates were comparable, thereby indicating the robustness of the proposed model. A population pharmacokinetic model that satisfactorily described the disposition and variability of meropenem in our Japanese population is described. NONMEM analysis showed that the clearance of meropenem depended on modified serum creatinine. The results of this study should help Japanese patients on meropenem by improving the prediction accuracy of dosing using the Bayesian method.
      pubtype: Academic Journal
      doctype:
        equations & formulas
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N